Structure/function in neuroprotection and apoptosis

Annals of Neurology

Volumn 44, Issue 3 SUPPL. 1, 1998, Pages

  Borden, Katherine L B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

APOPTOSIS; CONFERENCE PAPER; DEGENERATIVE DISEASE; HUMAN; NEUROPATHOLOGY; NEUROPROTECTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; SENILE PLAQUE; STRUCTURE ACTIVITY RELATION;

EID: 0031696092     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440711     Document Type: Conference Paper

References (37)

1. Nakajo S, Omata K, Aiuchi T, et al. Purification and characterization of a novel brain specific 14-kDa protein. J Neurochem 1990;55:2031-2038
2. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286
3. Irizarry MC, Kim T-W, McNamara M, et al. Characterization of the precursor protein of the non-Ab component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 1996;55:889-895
4. George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995;15:361-372
5. Marteaux L, Scheller RH. The rat brain synucleins: family of proteins transiently associated with neuronal membrane. Mol Brain Res 1991;11:335-343
6. Tobe T, Nakajo S, Tanaka A, et al. Cloning and characterization of the cDNA encoding a novel brain specific 14 kDa protein. J Neurochem 1992;59:1624-1629
7. Shibayama-Imazu T, Okahashi I, Omata K, et al. Cell and tissue distribution and developmental change of neuron specific 14 kDa phosphoneuroprotein. Brain Res 1993;622:17-25
8. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
9. Han H, Weinreb PH, Lansbury PT. The core of Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid - is NAC a common trigger or target in neurodegenerative disease? Chem Biol 1995;2:163-169
10. Ji H, Liu Y, Jia T, et al. Identification of a breast cancer specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 1997;57:759-764
11. Jensen PH, Hojrup P, Hager H, et al. Binding of Aβ to α and β synucleins: identification of segments of α-synuclein/NAC precursor that bind Aβ and NAC. Biochem J 1997;323:539-546
12. Jensen PH, Sorensen ES, Petersen TE, Gliemann J, Rasmussen LK. Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase catalyses cross-linking to Alzheimer disease amyloid βA4 peptide. Biochem J 1995;316:91-94
13. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14:467-475
14. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997; 388:839-840
15. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein family gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
16. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 1996;35:13709-13715
17. Artymiuk PJ, Blake CCF. Refinement of human lysozyme at 1.5Å resolution analysis of non-bonded and hydrogen bond interactions. J Mol Biol 1981;152:737-762
18. Funahashi J, Takano K, Ogasahara K, Yamagata Y, Yutani K. The structure, stability and folding process of amyloidogenic mutant lysozyme. J Biochem 1996;120:1216-1223
19. Booth DR, Sunde M, Bellotti V, et al. Instability, unfolding and aggregarion of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997;385:787-793
20. Creighton T. Proteins: structures and molecular properties. New York: WH Freeman, 1993
21. Minor DL, Kim PS. Context dependent secondary structure formation of a designed protein sequence. Nature 1996;380: 730-734
22. Dalal S, Balasubramanian S, Regan L. Protein alchemy: changing β-sheet into α-helix. Nature Struct Biol 1997;4:548-552
23. Borden KLB, Campbell-Dwyer EJ, Salvato MS. The promyelocytic leukemia protein nuclear body function: new insights from lymphocytic choriomeningitis virus infection. J Virol 1998;72:758-766
24. Borden KLB, Campbell-Dwyer EJ, Salvato MS: The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING. FEBS Lett 1997;418:30-34
25. Borden KLB, Boddy MN, Lally J, et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein, pml. EMBO J 1995;14:1532-1541
26. Borden KLB, Lally JM, Martin SR, et al. Novel topology of a zinc-binding domain involved in regulating early Xenopus development. EMBO J 1995;14:5947-5956
27. Le XF, Yang P, Chang KS. Analysis of the growth and transformation suppressor domains of the promyelocytic leukemia gene PML. J Biol Chem 1996;271:130-135
28. Sirover MA. Role of the glycolytic protein, glyceraldehyde 3-phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 1997;66:133-140
29. +-binding region (Rossmann fold). J Biol Chem 1995;270:2755-2763
30. Schultz DE, Hardin CC, Lemon SM. Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5′-nontranslated RNA of hepatitis A virus. J Biol Chem 1996;271: 14134-14142
31. Singh R, Green MR. Sequence specific binding of transfer RNA by glyceraldehyde 3-phosphate dehydrogenase. Science 1993;259:365-368
32. Ishitani R, Chuang D-M. Glyceraldehyde 3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 1996;93:9937-9941
33. Minton AP, Wilf J. Effect of macromolecular crowding upon the structure and function of an enzyme: glyceraldehyde 3-phosphate dehydrogenase. Biochemistry 1981;20:4821-4826
34. Kim H, Feil IK, Verlinde CLMJ, Petra PH, Hol WGJ. Crystal structure of glycosomal glyceraldehyde 3-phosphate dehydrogenase from Leishmania mexicana: implications for structure based drug design and a new position for the inorganic phosphate binding site. Biochemistry 1995;34:14975-14986
35. Skarzynski T, Wonacott AJ. Coenzyme induced conformational changes in glyceraldehyde 3-phosphate dehydrogenase from Bacillus stearothermophilus. J Mol Biol 1988;203:1097-1118
36. Leslie AGW, Wonacott AJ. Structural evidence for ligand induced sequential conformational changes in glyceraldehyde 3-phosphate dehydrogenase. J Mol Biol 1984;178:743-772
37. Nicholls A. GRASP: graphical representation and analysis of surface properties. New York: Columbia University Press, 1993